Andere Sprachen scPharmaceuticals Inc.

Aktien

A2H7XD

US8106481059

SCPH

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
4,5 ^USD	-2,39 %		+1,81 %	-28,23 %

24.04.	ScPharmaceuticals Inc. gibt die Aufnahme des ersten Teilnehmers in die pharmakokinetische Zulassungsstudie von Furoscix Auto-Injector (Furosemid 80Mg/Ml) Injektion bekannt	CI
13.03.	Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection	24.04.
ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection	24.04.
ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13.03.
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	13.03.
ScPharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024	06.03.
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	28.02.
ScPharmaceuticals Expects Higher Q4 Product Sales	04.01.
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue	04.01.
ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023	04.01.
ScPharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08.11.
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update	08.11.
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	01.11.
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	31.10.23
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05.10.23
ScPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives	19.09.23
Scpharmaceuticals Announces Positive Feedback from Two Fda Meetings on Key Long-Term Growth Initiatives	19.09.23
ScPharmaceuticals Inc.(NasdaqGS:SCPH) added to S&P Global BMI Index	18.09.23
ScPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference	05.09.23
ScPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update	10.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen scPharmaceuticals Inc.

Aktien

A2H7XD

US8106481059

SCPH

Andere Sprachen

Filter